Crystal Winkeler
Private Equity Investor chez BioGenerator (Venture Capital)
Profil
Crystal Winkeler, PhD, joined the BioGenerator team as Managing Director of BioGenerator Ventures in 2022.
She focuses on building and investing in biopharma companies.
Prior to this role, Crystal was COO and Vice President of R&D of Canopy Biosciences, a Bruker Company (Nasdaq: BRKR).
Crystal co-founded Canopy Biosciences and was instrumental in the growth of the company, including PE-backed acquisitions of both Zellkraftwerk, GmbH and Core Diagnostics, LLC.
She led efforts in fundraising, technology sourcing and licensing, commercialization, operations, and business development.
At the time that she joined BioGenerator, Crystal led a large international team across four sites.
Crystal also brings experience in life science investing from her time as a VC Fellow and Senior Analyst with BioGenerator Ventures.
During her initial tenure with the team, she participated in multiple investments, including Arch Oncology, Confluence Life Sciences (trading as NASDAQ: ACRS), Immunophotonics, Benson Hill (NYSE: BHIL), CoverCress, and Medibeacon.
Additionally, Crystal has spent time speaking to various student groups about entrepreneurship and judging pitch competitions.
Crystal holds a PhD in Molecular Cell Biology from Washington University in St. Louis, where her research focused on analyzing the genetics of a mouse model for studying osteoclasts and the role of the ARF tumor suppressor in post-mitotic cells.
She was also active in student-led organizations working with investment groups and entrepreneurs.
Outside of the office, she enjoys spending time with her husband and two children, playing board games, euchre, and traveling.
Postes actifs de Crystal Winkeler
Sociétés | Poste | Début |
---|---|---|
BioGenerator (Venture Capital)
BioGenerator (Venture Capital) Investment ManagersFinance BioGenerator (Venture Capital) (BioGenerator) is a venture capital subsidiary of BioGenerator founded in 2003. The firm is headquartered in St. Louis, Missouri. | Private Equity Investor | 01/05/2022 |
Anciens postes connus de Crystal Winkeler
Sociétés | Poste | Fin |
---|---|---|
Canopy Biosciences LLC
Canopy Biosciences LLC Electronic Equipment/InstrumentsElectronic Technology Canopy Biosciences LLC engages in the provision of products and services for gene editing, gene expression analysis and regulation, and bioprocessing. It offers crispr complete kits, mirna crispr knockout kits, clia certified services, compbio, mirna mimics, and cho complete. The company was founded by David Adam Smoller, Edward J. Weinstein and Crystal Winkeler in 2016 and is headquartered in St. Louis, MO. | Fondateur | 30/04/2022 |
BRUKER CORPORATION | Directeur des opérations | 30/04/2022 |
Formation de Crystal Winkeler
Bradley University | Undergraduate Degree |
Washington University in St. Louis | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
BRUKER CORPORATION | Health Technology |
Entreprise privées | 2 |
---|---|
BioGenerator (Venture Capital)
BioGenerator (Venture Capital) Investment ManagersFinance BioGenerator (Venture Capital) (BioGenerator) is a venture capital subsidiary of BioGenerator founded in 2003. The firm is headquartered in St. Louis, Missouri. | Finance |
Canopy Biosciences LLC
Canopy Biosciences LLC Electronic Equipment/InstrumentsElectronic Technology Canopy Biosciences LLC engages in the provision of products and services for gene editing, gene expression analysis and regulation, and bioprocessing. It offers crispr complete kits, mirna crispr knockout kits, clia certified services, compbio, mirna mimics, and cho complete. The company was founded by David Adam Smoller, Edward J. Weinstein and Crystal Winkeler in 2016 and is headquartered in St. Louis, MO. | Electronic Technology |